Invitation to participate in the CLAE WWE Survey.
You are being asked to participate in a research study that we are conducting. Participation is voluntary.
Why is this study being done?
The care of Women with Epilepsy (WWE) is complex and especially important during their childbearing years.
There is felt to be a heterogeneity in practice across Canada in how neurologists, epilepsy specialists or nurse practitioners approach this patient population.
We wanted to sample this diversity in practice by way of a questionnaire.
What does participation in the study involve?
We will ask the participants to complete a short 7 minute survey about their current practices in the care of WWE.
What are the risks?
There are no major risks associated with participating in this study. You may feel uncomfortable answering some questions however you can refrain from answering any question at any time.
What are the benefits?
By taking part in these sessions, you will have the opportunity to inform different organizations such as the Canadian League Against Epilepsy (CLAE), Canadian Neurological Sciences Federation (CNSF) and Canadian Epilepsy Nursing Group (CENG) on how WWE are currently managed in Canada.
Gaps in care will be identified and additional training materials may be developed to address these gaps and ensure all WWE receive the most up to date, standard of care available.
Do you have to participate?
Your participation is voluntary and choosing not to participate will have no effect on your current or future relationship with any of the above-cited organizations in the future.
You will not be paid for participating in this study.
What about confidentiality and privacy?
Your confidentiality and privacy will be protected at all times unless release is required by law. No personal health identifiers are collected during this survey.
How are the findings to be shared?
We will make every effort to ensure the findings of this strategy are shared in a timely manner with Canadian practitioners taking care of WWE. We will also present outside the university communities at various professional conferences and through publications.
A summary will also be published on the CLAE website.
Questions about the study
If you have any questions about this study, please feel free to contact Dr. Tadeu Fantaneanu, whose coordinates may be found below.
Address: 1053 Carling Ave, C2 Neurosciences clinic, C2194
Ottawa Ontario, K1Y 4E9
Tel: 613 798 5555 ext 17932
Fax: 613 761 5360
If you would like to participate in this study please click on the button below to access the Survey:
By completing the survey you are providing your consent to participate in the study.
Esther Bui, MD, FRCPCTadeu A. Fantaneanu, MDCM, CSCN (EEG), FAES, FRCPC.